Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Confluent

3 Software Stocks Analysts Like Better Than Palantir

Palantir has had a remarkable rally so far in 2023. However, there are three other software stocks that analysts believe have more upside from current levels.

Organ Transplant Leader TransMedics Eyes New Buy Point After 800% Advance

Organ Transplant Leader TransMedics Eyes New Buy Point After 800% Advance

Among the best stocks to buy and watch, organ transplant leader TransMedics has a fresh buy point after an 800% advance since February 2022.

Investors Business Daily

Nasdaq Leads Upside In Mixed Stock Market; What Is The Next Entry Point In Palantir Stock?

Nasdaq Leads Upside In Mixed Stock Market; What Is The Next Entry Point In Palantir Stock?

Looking at the top industry groups of the day, a handful claimed gains of 2% or more.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Cloud Stock Improves Bottom Line, Finally Heads For Profitability

Cloud data streaming stock Confluent is approaching profitability and nears a buy point. This cloud data streaming stock sees a total addressable market hitting $100 billion by 2025.

Investors Business Daily

What 8 Analyst Ratings Have To Say About Confluent

Analysts have provided the following ratings for Confluent (NASDAQ:CFLT) within the last quarter:

HubSpot And 2 Other Stocks Insiders Are Buying

Although the Dow Jones dipped sharply by over 1,150 points on Wednesday, there were a few notable insider trades.

Expert Ratings for Confluent

Within the last quarter, Confluent (NASDAQ:CFLT) has observed the following analyst ratings:

inkl

Read news from The Economist, FT, and more,
with one subscription

Insiders Buy More Than $15M Of 3 Stocks

Insiders Buy More Than $15M Of 3 Stocks

Although US stock futures traded higher this morning on Thursday, there were a few notable insider trades.

Analyst Ratings for Confluent

Analyst Ratings for Confluent

Analysts have provided the following ratings for Confluent (NASDAQ:CFLT) within the last quarter:

Medical devices maker Confluent sets up pilot plant

Medical devices maker Confluent sets up pilot plant

Company chooses Hyderabad for India foray, to manufacture Nitinol products

What 7 Analyst Ratings Have To Say About Confluent

What 7 Analyst Ratings Have To Say About Confluent

Confluent (NASDAQ:CFLT) has observed the following analyst ratings within the last quarter:

What 8 Analyst Ratings Have To Say About Confluent

What 8 Analyst Ratings Have To Say About Confluent

Within the last quarter, Confluent (NASDAQ:CFLT) has observed the following analyst ratings:

Analyst Ratings For Confluent

Analyst Ratings For Confluent

Analysts have provided the following ratings for Confluent (NASDAQ:CFLT) within the last quarter:

Why Confluent Shares Are Falling

Why Confluent Shares Are Falling

Confluent Inc (NASDAQ: CFLT) shares are trading lower by 9.3% at $66.38 Friday morning after the company reported fourth-quarter earnings results.

Get all your
news in one place.

100’s of premium titles.
One news app.

This Data Infrastructure Company Has A Better 6-Month Return Than Disney, Apple, Netflix And Microsoft

Confluent Inc (NASDAQ: CFLT) is a leader in helping firms identify and capture data trends, and over the past six months, has treated bullish traders and investors to eye-popping returns.

Why Are Confluent Shares Trading Higher Today?

Confluent, Inc (NASDAQ:CFLT), the data streaming platform to set data in motion, collaborated with Amazon.com Inc (NASDAQ:AMZN) Amazon Web Services, Inc (AWS). Under this five-year agreement, Confluent and AWS have committed to joint go-to-market initiatives to help organizations accelerate their cloud adoption journey with real-time data. Stephen Orban, GM, AWS Marketplace and Control Services, AWS, said,…

Analyst Ratings For Confluent

Over the past 3 months, 4 analysts have published their opinion on Confluent (NASDAQ:CFLT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

IBD MarketSmith

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

237,081 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play